Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis.

Hao Niu Jiayi Ma Inmaculada Medina-Caliz Mercedes Robles-Diaz Elvira Bonilla Marwan S Ghabril María Isabel Lucena Ismael Alvarez-Alvarez Raúl Jesús Andrade

Published in: Alimentary pharmacology & therapeutics (2022)

Corticosteroid therapy did not worsen outcome in DILI patients. Indeed, corticosteroid administration was associated with a greater rate of normalisation of liver enzymes in patients with serious DILI.

Keyphrases

drug induced
end stage renal disease
ejection fraction
newly diagnosed
clinical trial
prognostic factors
emergency department
cross sectional
study protocol
patient reported outcomes
risk assessment
climate change
cell therapy
adverse drug